| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |